INTER PARFUMS (EPA:ITP) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
INTER PARFUMS

BRIEF

published on 12/04/2025 at 15:03, 14 hours 21 minutes ago

Inter Parfums: Declaration of Voting Rights and Shares as of November 30, 2025

Share Capital Voting Rights Euronext Actions Inter Parfums
BRIEF

published on 11/19/2025 at 07:05, 15 days 22 hours ago

Interparfums Sets Ambitious 2026 Objectives Amid Market Challenges

Interparfums Fragrance Market Sales Forecasts Brand Portfolio 2026 Growth
REGULATED PRESS RELEASE

published on 11/19/2025 at 07:00, 15 days 22 hours ago

2026 outlook
Interparfums anticipates €890m in 2026 sales with new brand launches and international distribution expansion. Strategic acquisitions set stage for future growth

Acquisitions Interparfums Sales Forecast Fragrance Market Brand Launches
BRIEF

published on 11/06/2025 at 22:05, 28 days 7 hours ago

Interparfums SA Proposes Merger with Interparfums Holding SAS

French Company Shareholders Meeting Financial Documents AMF Decision Interparfums Merger
REGULATED PRESS RELEASE

published on 11/06/2025 at 22:00, 28 days 7 hours ago

Merger by absorption of the French company Interparfums Holding SAS by the French company Interparfums SA
French company Interparfums SA plans merger by absorption with Interparfums Holding SAS. AMF decides no public offer needed, General Meeting on December 17, 2025, details available online

Shareholders Merger AMF Interparfums General Meeting
BRIEF

published on 11/06/2025 at 12:55, 28 days 16 hours ago

INTER PARFUMS: Declaration of Voting Rights for October 2025

Share Capital Voting Rights Actions Share Buyback Inter Parfums
BRIEF

published on 10/31/2025 at 18:05, 1 month 4 days ago

Interparfums Proposes Merger to Simplify Control Structure

Euronext Paris Share Capital Merger Simplification Interparfums SA
REGULATED PRESS RELEASE

published on 10/31/2025 at 18:00, 1 month 4 days ago

Project to simplify the control structure. Merger by absorption of the French company Interparfums Holding SAS by French company Interparfums SA
Interparfums SA plans to absorb Interparfums Holding SAS, simplifying its structure. Merger to be approved at Dec 2025 Shareholders' Meeting. Exchange ratio & new share allocation detailed

Shareholders Merger Interparfums Exchange Ratio Absorption
BRIEF

published on 10/21/2025 at 07:05, 1 month 14 days ago

Interparfums Reports Positive Nine-Month Sales in 2025

Geopolitical Impact North America Market Interparfums Sales Jimmy Choo Growth Lacoste Fragrances
REGULATED PRESS RELEASE

published on 10/21/2025 at 07:00, 1 month 14 days ago

2025 nine-month sales. €710m at constant exchange rates (+4.4%)
Interparfums reports €710m sales in first nine months of 2025, up 4.4% at constant exchange rates. Strong performance in flagship brands with Jimmy Choo fragrances driving growth

Sales Interparfums Growth Fragrances 2025

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 54 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 9 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 40 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE